Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC

Tokyo, Japan and Cambridge, UK, 3 April 2024 - Nxera Pharma (“Nxera” or “the Company”; TSE: 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region. Mr. Branch will join Nxera’s global Business Development team that is led by Dr. Marcus Messenger. He will be based in Nxera’s Tokyo office and will oversee Japan and regional disease area strateg

Related Keywords

Japan ,United Kingdom ,Seoul ,Soult Ukpyolsi ,South Korea ,Cambridge ,Cambridgeshire ,United States ,Columbia University ,New York ,London ,City Of ,France ,Tokyo ,Japanese ,Chris Cargill ,Frazer Hall ,Maya Bennison ,Kentaro Tahara ,Erica Hollingsworth ,Nxera Pharma ,Shinichiro Nishishita ,Nxerapharma Youtube ,Sosei Heptares ,Patrick Branch ,Masters Of Public Health ,University Of Nottingham ,University Of London ,Head Of Business Development For Japan ,Mailman School Of Public Health New York ,Medistrava Consulting For International Media ,Sosei Group Or Heptares ,Tokyo Stock Exchange ,Business Development ,Linkedin ,Sosei Group ,Public Health ,Mailman School ,International Media ,Marcus Messenger ,Nxera Pharma Group ,Strategic Consulting ,